Related Experiment Video
Updated: Oct 1, 2025

08:56
A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
Published on: December 5, 2016
11.1K
N6-methyladenosine (m6A) RNA modification in tumor immunity
Siyi Zheng1, Hui Han1, Shuibin Lin2
1Center for Translational Medicine, Precision Medicine Institute, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
Cancer Biology & Medicine
|March 7, 2022
Summary
Epigenetic regulator N6-methyladenosine (m6A) modification is crucial for tumor immune evasion and progression. Understanding m6A
Area of Science:
- Oncology
- Immunology
- Epigenetics
Background:
- Cancer progression is linked to the tumor microenvironment and immune evasion.
- Epigenetic regulators are key in shaping the tumor microenvironment and immune recognition.
- N6-methyladenosine (m6A) modification, a prevalent mRNA epigenetic mark, influences tumorigenesis and progression.
Purpose of the Study:
- To review the roles of m6A modification in tumor immunoregulation.
- To focus on anti-tumor immune cell processes and immune-associated molecules/pathways.
- To discuss the correlation between m6A-related risk signatures and the tumor immune microenvironment.
Main Methods:
- Literature review of recent research on m6A modification in cancer immunity.
- Analysis of studies focusing on m6A's impact on immune cells and pathways.
- Examination of m6A regulators' prognostic and therapeutic value.
Main Results:
- Abnormal m6A modification critically regulates tumor immunity.
- m6A modification influences anti-tumor immune responses and immune-associated pathways.
- m6A-related risk signatures correlate with the tumor immune microenvironment landscape.
Conclusions:
- m6A modification plays a significant role in tumor immunoregulation.
- m6A regulators have prognostic and therapeutic potential in various cancers.
- Further research into m6A modification is vital for cancer immunotherapy development.
Related Concept Videos
RNA Editing
9.2K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.2K
MicroRNAs
3.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K
Transfer RNA Synthesis
12.3K
One of the unique features of tRNA is the presence of modified bases. In some tRNAs, modified bases account for nearly 20% of the total bases in the molecule. Altogether, these unusual bases protect the tRNA from enzymatic degradation by RNases.
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
12.3K
Abnormal Proliferation
4.7K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
RNA Stability
34.1K
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
34.1K
Tumor Immunotherapy
708
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
708

